AKT1 and Obesity: Changes in IR typically exhibit an association with lower insulin signaling protein activity, and our risperidone-treated mice with obesity and hyperglycemia exhibited impaired glucose homeostasis due to the reduction of Akt phosphorylation and GLUT4 expression.